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Abstract: The ability of plants to serve as a production system for bacterial lipoprotein vaccines has been investigated. 
First, the effect of high-level expression of the Borrelia burgdorferi outer membrane protein A (OspA), a prototype vac-
cine against Lyme disease, has been examined by a proteomics approach. Analysis by 2D-PAGE of wild type tobacco 
plants and transplastomic plants accumulating recombinant OspA showed no apparent differences in protein pattern ex-
cept for OspA. However, presence of the bacterial signal sequence limits transgene accumulation. As an alternative ap-
proach OspA was produced in Nicotiana benthamiana plants by transient expression via a deconstructed tobacco mosaic 
virus-based system. While rapid expression of OspA could be achieved, no palmitoylation occurred with the genuine bac-
terial sequence. In contrast, modification of the N-terminus with an eukaryotic sequence motif resulted in palmitoylation 
of OspA. This study shows that plants provide multiple expression strategies and could serve as a versatile production 
platform for recombinant lipidated subunit vaccines. 
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INTRODUCTION 
 Bacteria exhibit on their outer surface a diverse set of 
proteins sharing a unique lipid modification. The so called 
bacterial lipoproteins play important roles in numerous 
physiological processes [1, 2] and also in host-pathogen in-
teraction and pathogenesis. They are important targets for the 
immune system and for several pathogens, lipoproteins have 
been identified as potential vaccine candidates, e.g. from 
Streptococcus sp. [3] or Neisseria meningitides [4]. The most 
prominent example is the outer surface protein A (OspA) of 
the Lyme disease agent Borrelia burgdorferi, which has 
been already used as a vaccine in humans [5, 6]. In the case 
of OspA it has been shown that the unique lipid moiety is 
essential for immunogenicity and that a non-lipidated form 
did not induce protective immunity in mice [7, 8]. Therefore, 
production of the unique lipoproteins so far relies on bacte-
rial expression systems. 
 Bacterial lipoproteins contain a typical N-terminal signal 
peptide recognized by the enzyme diacylglyceryl transferase 
(Lgt), which attaches a diacylglycerol to the thiol of a con-
served cysteine which is an invariant part of the lipobox mo-
tif [9]. Cleavage of the signal peptide by signal peptidase II 
results in the unique Pam2Cys-structure at the amino termi-
nus of the protein. Contingently, a third palmitic acid could 
be attached to the free amino group in Gram- bacteria, result-
ing in a Pam3Cys-structure, as present in OspA. It has been 
shown that OspA does not accumulate to very high levels 
when expressed in E. coli possibly due to interference with 
the export of host proteins [10]. Hence, production of large 
amounts of lipoproteins is limited by the processing capacity 
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of the host bacterium. As an alternative system, we used 
plants as an expression host for OspA. 
 Plants have been widely assayed as a production platform 
for recombinant proteins and in particular for subunit vac-
cines [11, 12]. Especially the use of chloroplast transforma-
tion has enabled the accumulation of recombinant proteins at 
extraordinary high levels. In the case of the TetC fragment 
from Tetanus toxin, 25% of the total cellular protein (TSP) 
could be achieved by expression in the chloroplast [13], and 
22% TSP of a cholera toxin fusion could be produced [14]. 
Those are two examples of many showing that transplas-
tomic plants have an enormous potential as protein factories. 
However, generation of plants is time consuming and fre-
quently transgene expression reduces viability of plants [13, 
15].  
 As an alternative, viral vectors can be used for transient 
expression in plants when the gene of interest is placed under 
the control of the strong coat protein promoter. The advan-
tage of the system is, that extremely high levels of recombi-
nant protein can be produced due to viral amplification in a 
very short time (days) [16]. Especially the system using in 
planta assembly of complete viral vectors from separate 
modules has been proven to be highly suitable for evaluating 
viral transgene expression in plants [17-19]. 
 In the course of providing a plant-produced recombinant 
OspA vaccine we have recently shown that recombinant 
OspA can be produced in tobacco chloroplasts and that the 
protein is lipidated and immunogenic in mice [20]. However, 
while plants producing OspA at 1% of TSP were healthy, 
those accumulating OspA at 10% TSP were hampered in 
photosynthesis and unable to grow photoautotrophically 
[15], limiting the suitability of this production system. To  
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further understand and eventually overcome the effects 
which limit production of bacterial lipoproteins in chloro-
plasts, we wanted to use a proteomics approach to indentify 
potentially differences in the plant cell protein inventory. 
Moreover, we used a transient approach as an alternative to 
produce OspA variants in either lipidated or non-lipidated 
form to provide a plant made vaccine candidate against 
Lyme disease. 
MATERIALS AND METHODS 
2D-PAGE 
 All chemicals and materials for 2D-PAGE were pur-
chased from GE Healthcare, Munich, Germany. Sequencing 
grade modified trypsin was obtained from Promega, Mann-
heim, Germany. All other chemicals and HPLC-solvents 
were acquired from Merck KGaA, Darmstadt, Germany. 
 Total protein for 2D-PAGE was isolated from transplas-
tomic plants grown under sterile conditions on sugar contain-
ing medium [15] after the method by [21]. Protein pellets 
were resuspended in R-buffer (7 M urea, 2 M thiourea, 2% 
CHAPS, 2% IPG buffer, 50 mM DTT) and the protein con-
tent of each sample was determined using the 2D Quant as-
say (GE Healthcare, Munich, Germany). Equal amounts of 
proteins were separated by 2D-PAGE. Therefore, isoelectric 
focusing was performed using the Ettan™ IPGphor™ II IEF 
System (GE Healthcare) to a total of 52 kVh. IPG strips (24 
cm, pH 3-10, non-linear) were incubated in 450 L re-
swelling buffer over night (7 M urea, 2 M thiourea, 2% 
CHAPS, 2% carrier ampholytes pH 3-10, 50 mM DTT). Of 
each protein 200 g (in 100 l) were loaded on IPG strips 
using sample cups at the acidic end of the IPG strip. Before 
transferring IPG strips onto 12.5% SDS polyacrylamide gels, 
proteins were reduced using 65 mM DTT and alkylated by 
280 mM iodoacetamide. Electrophoresis was performed us-
ing the EttanDalt™ system (GE Healthcare). Finally, gels 
were subjected to silver staining according to [22]. For im-
age analysis, gels were scanned with standardized parame-
ters and gel images were processed by the Delta2D™ Soft-
ware (Decodon, Greifswald, Germany).  
LC-MS/MS-Analysis 
 Sample preparation of all spots was performed according 
to the protocol of Shevchenko et al. [23] Briefly, gel spots 
were washed alternately twice for 10 min with 50 mM 
NH4HCO3 and 25 mM NH4HCO3 in 50% acetonitrile. The 
protein spots were vacuum dried prior to tryptic digestion. 
Gel pieces were rehydrated with 12.5 ng/L trypsin in 50 mM 
NH4HCO3. Incubation was performed over night at 37°C. 
The resulting peptides were extracted by addition of 15 L 
5% formic acid for 10 minutes. 
 The extracted peptides were separated using Ultimate™ 
3000 chromatography system (Dionex, Idstein, Germany) 
coupled to an ESI-MS. The sample was pre-concentrated on 
a 300 m ID 1 mm C18 trapping column. Afterwards, pep-
tides were separated on a 75 m ID C18 15 cm main column 
by a binary gradient composed of solvent A (0.1% formic 
acid) and solvent B (0.1% formic acid in 84% acetonitrile). 
Solvent B was increased from 5% to 95% in 55 minutes. The 
flow rate was set to 250 nL/min. Peptides were directly 
eluted into the ion trap LCQ Deca XPplus™ (Thermo Elec-
tron, Dreieich, Germany). MS-acquisition duty cycle was set 
up with 1 s survey scan and three dependent scans (each ap-
proximately 1 s). [24] 
 Generated data was processed using the search algorithm 
MASCOT™ (version 2.1, Matrix Science, London, UK 
[25]). Database searches were accomplished using Swiss-
Prot (version 2005, Geneva, Switzerland). As fixed modifi-
cation carbamidomethylation of cysteines was selected and 
oxidation of methionine as optional modification. As further 
parameters tryptic digest and up to one missed cleavages 
were considered for the search algorithms. Singly, doubly 
and triply charged ions were considered, respective mass 
tolerances were set to 1.5 Da. For MASCOT™ the minimum 
score was set to 35 for each peptide. All spectra were veri-
fied manually in order to avoid false positive hits derived 
from the search algorithms. Furthermore, each protein identi-
fication was based on at least 2 validated MS/MS-spectra 
Vector Cloning 
 For transient expression of OspA-variants, the sequence 
was PCR-amplified with primers adding a unique BsaI site 
five base pairs upstream of the coding sequence. Forward 
primers were 5´-AATTTGGTCTCAAGGTATGGCAAAAT  
ATTTATTGGGAATAGGTC-3´ for OA25, 5´-TTTGGTCT  
CAAGGTATGAAAAAATATTTATTGGG-3´ for OA27, 
5´- TCTTTGGTCTCAAGGTCCTCCATGGGATGTAAG-
CAAAATGTTAGCAGCC-3´for OT22, and 5´-TTTGGTCT  
CAAGGTATGTGTAAGCAAAATG-3´ for OT24. Reverse 
primer was as described in [15]. BsaI/XbaI-fragments were 
cloned into the magnICON 3´-module cloning vector pICH- 
10990, resulting in vectors pOA6125, pOA6127, pOT6122, 
and pOT6124. Plasmids were subsequently transferred to 
Agrobacterium tumefaciens GV3101 as described in [26]. 
Plant Transformation and Transient Expression 
 Transient expression was achieved by infiltrating Agro- 
bacterium suspension into leaves of Nicotiana benthamiana. 
Bacteria were grown to an OD600 of about 2, pelleted by 
centrifugation and resuspended in a five-fold volume of a 
solution containing 10 mM MES (pH 5.5) and 10 mM 
MgSO4. Suspensions of 3´-modules containing the OspA-
sequences were mixed with equal volumes of bacteria-
suspensions containing the 5´-module pICH15879 and the 
recombinase module pICH10881and infiltrated into leaves 
using a syringe without a needle. Ten days after infiltration 
leaves were harvested and frozen in liquid nitrogen prior to 
analysis. 
SDS-PAGE, Western Blotting, and Fluorography 
 For detection of recombinant OspA in transformed plants, 
100 mg of frozen plant material was homogenized in 150 L 
1SDS-sample buffer. The samples were heated to 90°C for 
10 minutes and applied to SDS-PAGE (12.5%). For detec-
tion of YFP, frozen leaf tissue was homogenized and ex-
tracted with 1PBS buffer. Protein content was determined 
with the BCA-protein assay kit (Pierce, Rockford, IL, USA) 
and 15 g protein were loaded onto SDS-PAGE (12.5%). 
 Proteins were transferred to a PVDF membrane (Hybond-
P PVDF-membrane, GE Healthcare) in a tank-blot-equip- 
ment at 100 V for one hour. After incubating with OspA-
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antibody (Fitzgerald, Concord, MA, USA) at 1:10,000 dilu-
tion, the membrane was washed for three times 15 minutes 
with 1PBST buffer (23 mM Na2HPO4, 17 mM Na2HPO4, 
100 mM NaCl, 0.1% (v/v) Tween 20). The washing steps 
were repeated after incubating the membrane with the HRP-
conjugated secondary antibody (dilution 1:20,000) for one 
hour. The detection followed with SuperSignal West Pico 
Chemiluminescent Kit (Pierce) according to the manual of 
the supplier. 
 For isotope labelling, protoplasts were isolated as de-
scribed by [27]. Approximately 5105 protoplasts in 200 l 
solution were incubated with 200 Ci [9, 10-3H] palmitic 
acid in 8 L DMSO (25%) for three hours. Isolation and 
detection of labelled proteins were done as described else-
where [15].  
 For detection of OspA-synthesis in protoplasts, 20 L of 
isolated protoplasts were incubated with 5SDS sample 
buffer at 90°C for ten minutes. Western blot analysis of re-
combinant protein was done as described above. 
Quantification of Recombinant Protein 
 To assess the amount of recombinant OspA accumulating 
after transient expression, crude extracts of total leaf protein 
was separated by SDS-PAGE. Along with the samples, de-
fined amounts of pure recombinant bacterial OspA were 
separated. Proteins were transferred to a PVDF-membrane 
and detected as described above. Quantification was done in 
a ChemiDoc XRS imager (BioRad, Munich, Germany). 
RESULTS AND DISCUSSION  
2D-Gel-Electrophoresis  
 Transplastomic tobacco plants accumulating recombinant 
OspA up to a level of 1% of the total soluble protein (TSP) 
were viable (line OA12) and almost indistinguishable from 
wild type (WT). In contrast, plants accumulating 10% OspA 
(line OA13) were unable to perform photosynthesis and re-
quired sugar for growth [15].  
 To assess the differences between the two transplastomic 
lines and wild type we performed 2D-gel-electrophoresis of 
total cellular protein of the different plant lines. When com-
paring the gels only protein spots with an at least 3-fold 
change in abundance were considered differential. In lines 
OA12 and OA13, three additionally, highly abundant protein 
spots occurred (Fig. 1) which were identified as OspA using 
nano-LC-MS/MS (data not shown). In general, most of the 
spots in the 2D-gels of the transplastomic lines slightly de-
creased in comparison to WT, but less than factor 3. This 
might be due to the constant total protein amount applied to 
the gels, were high-level of recombinant protein is on the 
expense of total protein.  
 No significant increase in these spots was detected from 
the OA12- to the OA13-lines presumably due to the satura-
tion of the silver stained spots limiting the dynamic range of 
the 2D-gel-electrophoresis. However, the phenotypical 
changes of the mutants compared to WT are not reflected in 
the 2D-gel-pattern representing mostly high-abundant, solu-
ble proteins. Thus, these changes are either due to steric rea-
sons or are induced by alteration of proteins not visible on 
the 2D-gels (e.g. low-abundant proteins). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (1). 2D-PAGE of Nicotiana tabacum wild type (wt), OA12 and 
OA13 mutant leafs. While most of the protein spots are slightly 
down-regulated in the mutants three highly abundant protein spots 
arise from which OspA can be identified in all cases. 
Production of OspA Variants via a Transient Tobacco-
Mosaic Virus-Based Expression System 
 To evaluate OspA accumulation and palmitoylation in 
plant cells we used viral transient expression mediated by 
Agrobacterium transfection of Nicotiana benthamiana plants 
[17]. To determine protein palmitoylation in dependence of 
the signal sequence (SS), four different constructs were 
cloned (Table 1).  
 Variant OA27 exhibited the genuine OspA-sequence, 
while OA25 had an amino acid exchange in position 2 (Lys 
 Ala). The variant OT24 was lacking the N-terminal SS 
and was identical to the non-palmitoylated chloroplast vari-
ant OT11 [20]. Additionally, a truncated form OT22 was 
made which exhibited an N-terminal sequence (Met-Glu-
Cys-) known to lead to palmitoylation and/or myristoylation 
in eukaryotic cells (e.g. G-protein subunit s [36]). This pro-
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tein should serve as a control to determine if a recombinant 
protein could be lipidated in the plant cell cytoplasm.  
 
Table 1. N-terminal Sequences of Constructs Used in this 
Study 
Name of Construct N-terminal Sequence 
OA12/13 MAKYLLGIGLILALIACKQ… 
OA25 MAKYLLGIGLILALIACKQ… 
OA27 MKKYLLGIGLILALIACKQ… 
OT22  MGCKQ… 
OT24  MCKQ… 
 
 For Agrobacterium-mediated viral transient expression, 
plants were infiltrated with bacteria suspensions and crude 
leaf extracts were analyzed after ten days for OspA-
accumulation.  
 
 
 
 
 
 
 
 
Fig. (2). Immunoblot and 
3
H-palmitic acid incorporation analysis of 
different OspA-variants after transient expression in Nicotiana 
benthamiana. (A) Crude extracts of total proteins after ten days 
from transfection were separated on SDS-PAGE and probed with 
anti-OspA monoclonal antibody. (B) Isolated protoplasts were 
lyzed, subjected to SDS-PAGE, and analyzed. (C) Protoplasts were 
incubated with 
3
H-palmitic acid and OspA was subsequently iso-
lated via metal affinity chromatography. Protein was separated by 
SDS-PAGE and analyzed by fluorography. Note the slightly lower 
size of OT22 compared to OA12 due to the lack of the signal se-
quence in OT22. 
  As shown in Fig. (2A), all lines produced significant 
amounts of recombinant OspA (compared to OA12 from 
chloroplasts). To investigate protein palmitoylation, proto-
plasts were prepared from ten days old leaves and checked 
again for OspA-content (Fig. 2B). While OspA could be 
detected in lines OA12 (control), OT22, and OT24, no OspA 
was found in protoplasts of lines OA25 or OA27. Analysis 
of the bacterial SS of OspA with TargetP [29] provided evi-
dence that the genuine OspA SS could act as a presequence 
for targeting the protein to the apoplast. In fact, a previous 
study showed that OspA is secreted when expressed in Nico-
tiana tabacum suspension cells [30]. Hence, full-length 
OspA variants could not be detected in protoplasts. 
Analysis of Palmitoylation 
 To determine if OspA-variants are palmitoylated in the 
cytoplasm, labeling of isolated protoplasts with 
3
H-palmitic 
acid was performed. While the chloroplast-produced OA12 
was palmitoylated (Fig. 2C), only OT22 from the cytosol-
produced variants showed a label and OT24 did not. This is 
proof that the N-terminal Met-Gly-Cys-motif facilitates 
palmitoylation of the recombinant OspA in the cytosol while 
the motif Met-Cys- does not. However, eukaryotic S-
Acylation is clearly different from bacterial lipoproteins 
which exhibit a diacylglycerol attached to the thiol group of 
cysteine. It has been shown in the case of the Plasmodium 
falciparum antigen LSA that the addition of a single palmitic 
acid to a peptide strengthens its immunogenicity in the ab-
sence of adjuvant [31]. It needs to be tested in which way 
this modification modulates the immunogenicity of the re-
combinant OspA and if OT22 also could serve as a vaccine. 
 Since OA25 and OA27 are excluded from the protoplast, 
no palmitoylation could be detected. However, lipidation of 
full length OspA after transient expression is unlikely since 
prediction of the signal sequence indicated that the N-
terminal 23 amino acids are cleaved during transport to the 
apoplast. This would eliminate the sole cysteine in position 
17 and therefore, palmitoylation of OspA could not occur. 
 
 
 
 
 
 
Fig. (3). Immunoblot for quantification of OspA after transient 
expression. Defined amounts of recombinant bacterial OspA (recO-
spA) were applied to Western blot and intensities of signals com-
pared to crude protein extracts from infiltrated plants (correspond-
ing to 7 mg of leaf). The amount of OspA from construct OA25 
was determined as 15 g/g fresh leaf. 
 Although no optimization of transient OspA-production 
was performed at this stage of the study, it was clearly 
shown that OspA could be produced at considerable levels 
compared to chloroplast produced OspA. For OA25 we de-
termined an OspA amount of about 15 g/g (Fig. 3), which 
is roughly 1/3 of the OspA-content of the transplastomic line 
OA12. With the use of more advances expression vectors it 
should be feasible to further enhance this amount [32].  
 Especially the ease and speed of the system made rapid 
analysis of different constructs possible in a very short time 
(weeks) which should allow the identification of optimal 
conditions for expression. 
CONCLUSIONS  
 Plants are an extremely versatile expression platform for 
recombinant therapeutic proteins. The use of different cellu-
lar compartments and/or expression systems (stable vs. tran-
sient) provides a toolbox to determine the optimal solution 
for each single protein. Moreover, different posttranslational 
modifications can be achieved by targeting proteins to sub-
cellular locations and by utilizing either eukaryotic or pro-
karyotic signal sequences. As shown for OspA, several 
strategies should be examined to find optimal conditions for 
a given target protein. 
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